NCT05873036 is a NA clinical trial of Aerobic Training in Breast Cancer, sponsored by Superior University.

Who is sponsoring NCT05873036?

NCT05873036 is sponsored by Superior University.

What drugs are being tested in NCT05873036?

Interventions in NCT05873036: Aerobic Training, Progressive Resistance Training.

What condition does NCT05873036 study?

NCT05873036 studies Breast Cancer.

Is NCT05873036 still recruiting?

NCT05873036 is currently status unknown. Last updated 24 May 2023.

Last reviewed 2023-05-24 · How we verify

NCT05873036

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of AT & PR Training to Improve Functional Ability After Breast Cancer Surgery

Status unknown NA Last updated 24 May 2023

What this trial tests

NA trial testing Aerobic Training in Breast Cancer in 74 participants. Status unknown.

Timeline

1 April 2023

Primary endpoint
1 June 2023

31 August 2023

Quick facts

Lead sponsor	Superior University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	74
Start date	1 April 2023
Primary completion	1 June 2023
Estimated completion	31 August 2023
Sites	1 location across Pakistan

Drugs / interventions tested

Aerobic Training
Progressive Resistance Training

Conditions studied

Breast Cancer — all drugs for Breast Cancer →

Sponsor

Superior University

Who can join

Adults 35 to 65, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the effect of aerobic training and progressive resistance training to improve upper limb functional ability after breast cancer surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Aerobic Training

Trials testing the same drug.

NCT07414615 — Aerobic Training in Lower Extremity Lymphedema · NA · recruiting
NCT07133256 — Effects of Aerobic Versus Resistance Training on Bone Metabolism in Stage 3-4 Chronic Kidney Disease · NA · completed
NCT06308276 — Effects of Aerobic Versus Resistance Training in Post Percutaneous Coronary Intervention Obese Patients · NA · completed
NCT05921552 — Senior Adult Hepatobiliary Prehab Study · NA · active not recruiting
NCT05364632 — Aerobic Training Versus Behavioral Intervention to Increase Physical Activity in Patients With Asthma · NA · recruiting

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Superior University trials

Trials by the same sponsor.

NCT07521839 — Title of This Study is to Evaluate the Effects of Abdominal Drawing in Maneuver With Cross Pattern Limb Exercises in Pat · NA · active not recruiting
NCT07523425 — Collaborative vs Non-Immersive VR in Parkinson's Rehabilitation · NA · recruiting
NCT07068347 — Comparison Of VR & CPT, With And Without Lifestyle Modification, On ULD In Breast Cancer Survivors · NA · active not recruiting
NCT07336459 — AI-Driven MRF Type 2 Diabetes Integrating DHT IF and Resistance Training to OM and Functional Outcomes · NA · active not recruiting
NCT07385066 — Effects of (tDCS) Combined With Virtual Reality Versus CPT on Brain, Cognitive, and GMS in Children With DS. · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05873036 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Superior University
Last refreshed: 24 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05873036.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing